The University of Queensland

Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease

Nidorf, Stefan M., Layland, Jamie, Robinson, Philip C., Patel, Sanjay, Psaltis, Peter J. and Thompson, Peter L. (2022). Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease. Medical Journal of Australia, 216 (8), 385-387. doi: 10.5694/mja2.51488

COVID-19 therapeutics: challenges and directions for the future

Robinson, Philip C., Liew, David F. L., Tanner, Helen L., Grainger, John R., Dwek, Raymond A., Reisler, Ronald B., Steinman, Lawrence, Feldmann, Marc, Ho, Ling-Pei, Hussell, Tracy, Moss, Paul, Richards, Duncan and Zitzmann, Nicole (2022). COVID-19 therapeutics: challenges and directions for the future. Proceedings of the National Academy of Sciences, 119 (15) e2119893119, e2119893119. doi: 10.1073/pnas.2119893119

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Putman, Michael, Kennedy, Kevin, Sirotich, Emily, Liew, Jean W, Sattui, Sebastian E, Moni, Tarin T, Akpabio, Akpabio A, Alpizar-Rodriguez, Deshire, Angevare, Saskya, Beesley, Richard P, Berenbaum, Francis, Bulina, Inita, Chock, Yu Pei Eugenia, Conway, Richard, Duarte-García, Ali, Singh, Aman Dev, Duff, Eimear, Durrant, Karen L, Gheita, Tamer A, Hill, Catherine L, Howard, Richard, Hoyer, Bimba F, Hsieh, Evelyn, el Kibbi, Lina, Kilian, Adam, Kim, Alfred H J, Liew, David F L, Lo, Chieh, Mateus, Elsa F ... Simard, Julia F (2022). COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. The Lancet Rheumatology, 4 (4), e237-e240. doi: 10.1016/S2665-9913(22)00001-7

Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based study

Topless, Ruth K, Gaffo, Angelo, Stamp, Lisa K, Robinson, Philip C, Dalbeth, Nicola and Merriman, Tony R (2022). Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based study. The Lancet Rheumatology, 4 (4), e274-e281. doi: 10.1016/S2665-9913(21)00401-X

SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry

Liew, Jean, Gianfrancesco, Milena, Harrison, Carly, Izadi, Zara, Rush, Stephanie, Lawson-Tovey, Saskia, Jacobsohn, Lindsay, Ja, Clairissa, Hyrich, Kimme L., Gossec, Laure, Strangfeld, Anja, Carmona, Loreto, Schäfer, Martin, Frãzao-Mateus, Elsa, Bulina, Inita, Stafford, Frances, Tufan, Abdurrahman, Graver, Christine, Yardımcı, Gözde Kübra, Zepa, Julija, Al Emadi, Samar, Cook, Claire, Abutiban, Fatemah, Dey, Dfiza, Katigbak, Genevieve, Kaufman, Lauren, Kowalski, Emily, Martínez-Martínez, Marco Ulises, Patel, Naomi J. ... Yazdany, Jinoos (2022). SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry. RMD open, 8 (1) e002187, e002187. doi: 10.1136/rmdopen-2021-002187

Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry

Conway, Richard, Nikiphorou, Elena, Demetriou, Christiana A, Low, Candice, Leamy, Kelly, Ryan, John G, Kavanagh, Ronan, Fraser, Alexander D, Carey, John J, O’Connell, Paul, Flood, Rachael M, Mullan, Ronan H, Kane, David J, Ambrose, Nicola, Stafford, Frances, Robinson, Philip C, Liew, Jean W, Grainger, Rebecca, McCarthy, Geraldine M, Dahou, Brahim, Quintana, Rosana, Gómez, Gimena, Roberts, Karen, Baez, Roberto Miguel, Coello, Vanessa Castro, Salinas, María J. Haye, Maldonado, Federico Nicolas, Torres, Alvaro Andres Reyes, Alle, Gelsomina ... COVID-19 Global Rheumatology Alliance (2022). Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry. Rheumatology. doi: 10.1093/rheumatology/keac142

Gout and the COVID-19 pandemic

Tai, Vicky, Robinson, Philip C. and Dalbeth, Nicola (2022). Gout and the COVID-19 pandemic. Current opinion in rheumatology, 34 (2), 111-117. doi: 10.1097/BOR.0000000000000860

COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations

Grainger, Rebecca, Kim, Alfred H. J., Conway, Richard, Yazdany, Jinoos and Robinson, Philip C. (2022). COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations. Nature Reviews Rheumatology, 18 (4), 191-204. doi: 10.1038/s41584-022-00755-x

Waiting for JAK inhibitor safety data

Kragstrup, Tue Wenzel, Glintborg, Bente, Svensson, Annemarie L, McMaster, Christopher, Robinson, Philip C, Deleuran, Bent and Liew, David FL (2022). Waiting for JAK inhibitor safety data. RMD Open, 8 (1) e002236. doi: 10.1136/rmdopen-2022-002236

The impact of COVID-19 on rheumatology training: results from the COVID-19 Global Rheumatology Alliance trainee survey

Young, Kristen, Yeoh, Su-Ann, Putman, Michael, Sattui, Sebastian, Conway, Richard, Graef, Elizabeth, Kilian, Adam, Konig, Maximilian, Sparks, Jeffrey, Ugarte-Gil, Manuel, Upton, Laura, Berenbaum, Francis, Bhana, Suleman, Costello, Wendy, Hausmann, Jonathan, Machado, Pedro, Robinson, Philip, Sirotich, Emily, Sufka, Paul, Yazdany, Jinoos, Liew, Jean, Grainger, Rebecca, Wallace, Zachary and Jayatilleke, Arundathi (2022). The impact of COVID-19 on rheumatology training: results from the COVID-19 Global Rheumatology Alliance trainee survey. Rheumatology Advances in Practice, 6 (1) rkac001, rkac001. doi: 10.1093/rap/rkac001

Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

Ugarte-Gil, Manuel Francisco, Alarcón, Graciela S., Izadi, Zara, Duarte-García, Ali, Reátegui-Sokolova, Cristina, Clarke, Ann Elaine, Wise, Leanna, Pons-Estel, Guillermo J., Santos, Maria Jose, Bernatsky, Sasha, Ribeiro, Sandra Lúcia Euzébio, Al Emadi, Samar, Sparks, Jeffrey A., Hsu, Tiffany Y. -T., Patel, Naomi J., Gilbert, Emily L., Valenzuela-Almada, Maria O., Jönsen, Andreas, Landolfi, Gianpiero, Fredi, Micaela, Goulenok, Tiphaine, Devaux, Mathilde, Mariette, Xavier, Queyrel, Viviane, Romão, Vasco C., Sequeira, Graca, Hasseli, Rebecca, Hoyer, Bimba, Voll, Reinhard E. ... Yazdany, Jinoos (2022). Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance. Annals of the Rheumatic Diseases, 81 (7), annrheumdis-2021. doi: 10.1136/annrheumdis-2021-221636

Australian consensus statements for the assessment and management of non-radiographic axial spondyloarthritis

Truong, Steven L., McEwan, Tim, Bird, Paul, Lim, Irwin, Saad, Nivene F., Schachna, Lionel, Taylor, Andrew L. and Robinson, Philip C. (2022). Australian consensus statements for the assessment and management of non-radiographic axial spondyloarthritis. Rheumatology and Therapy, 9 (1), 1-24. doi: 10.1007/s40744-021-00416-7

Industry involvement in rheumatology consensus-based recommendations: a systematic review

Feterman Jimenez, Dominique, Duron, Garret, Hendin, Joshua, Mantovani Cardoso, Eduardo, Valenzuela-Almada, Maria O, Vallejo, Sebastian, Duarte-Garcia, Ali, Sufka, Paul, Whittle, Samuel L, Robinson, Philip C, Prokop, Larry J and Putman, Michael S (2022). Industry involvement in rheumatology consensus-based recommendations: a systematic review. The Lancet Rheumatology, 4 (2), e145-e152. doi: 10.1016/S2665-9913(21)00332-5

What does endemic COVID-19 mean for the future of rituximab?

Liew, David F L and Robinson, Philip C (2022). What does endemic COVID-19 mean for the future of rituximab?. The Lancet Rheumatology, 4 (1), e3-e5. doi: 10.1016/S2665-9913(21)00362-3

COVID-19 in pregnant women with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance

Bermas, Bonnie L., Gianfrancesco, Milena, Tanner, Helen L., Seet, Andrea M., Aguiar, Mathia C., Al Adhoubi, Nasra K., Al Emadi, Samar, Cunha, Bernardo M., Flood, Rachael, Kusevich, Daria A., McCarthy, Eoghan M., Patel, Naomi J., Ruderman, Eric, Sattui, Sebastian E., Sciascia, Savino, Siddique, Faizah, Valenzuela-Almada, Maria O., Wise, Leanna M., Worthing, Angus B., Zell, JoAnn, Bhana, Suleman, Costello, Wendy, Duarte-Garcia, Ali, Grainger, Rebecca, Gossec, Laure, Hausmann, Jonathan S., Hyrich, Kimme, Lawson-Tovey, Saskia, Liew, Jean W. ... Robinson, Philip C. (2022). COVID-19 in pregnant women with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance. The Journal of Rheumatology, 49 (1), 110-114. doi: 10.3899/jrheum.210480

Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease

Robinson, Philip C., Terkeltaub, Robert, Pillinger, Michael H., Shah, Binita, Karalis, Vangelis, Karatza, Eleni, Liew, David, Imazio, Massimo, Cornel, Jan H., Thompson, Peter L. and Nidorf, Mark (2022). Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease. The American Journal of Medicine, 135 (1), 32-38. doi: 10.1016/j.amjmed.2021.07.025

Dr. Conway et al reply

Conway, Richard, Brouwer, Elisabeth, van der Geest, Kornelis S.M., Mackie, Sarah L., Mehta, Puja, Putman, Michael, Robinson, Philip and Sattui, Sebastian (2022). Dr. Conway et al reply. The Journal of Rheumatology, 49 (1), 120.2-121. doi: 10.3899/jrheum.2100913

Mapping the human genetic architecture of COVID-19

Niemi, Mari E. K., Karjalainen, Juha, Liao, Rachel G., Neale, Benjamin M., Daly, Mark, Ganna, Andrea, Pathak, Gita A., Andrews, Shea J., Kanai, Masahiro, Veerapen, Kumar, Fernandez-Cadenas, Israel, Schulte, Eva C., Striano, Pasquale, Marttila, Minttu, Minica, Camelia, Marouli, Eirini, Karim, Mohd Anisul, Wendt, Frank R., Savage, Jeanne, Sloofman, Laura, Butler-Laporte, Guillaume, Kim, Han-Na, Kanoni, Stavroula, Okada, Yukinori, Byun, Jinyoung, Han, Younghun, Uddin, Mohammed Jashim, Smith, George Davey, Willer, Cristen J. ... Donohue, Chloe (2021). Mapping the human genetic architecture of COVID-19. Nature, 600 (7889), 472-477. doi: 10.1038/s41586-021-03767-x

Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al

Wallace, Zachary S, Sparks, Jeffrey A, Robinson, Philip C, Machado, Pedro M and Yazdany, Jinoos (2021). Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al. Annals of the Rheumatic Diseases. doi: 10.1136/annrheumdis-2021-220960

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

Marconi, Vincent C, Ramanan, Athimalaipet V, de Bono, Stephanie, Kartman, Cynthia E, Krishnan, Venkatesh, Liao, Ran, Piruzeli, Maria Lucia B, Goldman, Jason D, Alatorre-Alexander, Jorge, de Cassia Pellegrini, Rita, Estrada, Vicente, Som, Mousumi, Cardoso, Anabela, Chakladar, Sujatro, Crowe, Brenda, Reis, Paulo, Zhang, Xin, Adams, David H, Ely, E Wesley, Ahn, Mi-Young, Akasbi, Miriam, Altclas, Javier David, Ariel, Federico, Ariza, Horacio Alberto, Atkar, Chandrasekhar, Bertetti, Anselmo, Bhattacharya, Meenakshi, Briones, Maria Luisa, Budhraja, Akshay ... Zirpe, Kapil (2021). Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. The Lancet Respiratory Medicine, 9 (12), 1407-1418. doi: 10.1016/S2213-2600(21)00331-3

Longitudinal development of incident gout from low-normal baseline serum urate concentrations: individual participant data analysis

Robinson, Philip C., Frampton, Christopher, Phipps-Green, Amanda, Neogi, Tuhina, Stamp, Lisa, Taylor, William, Merriman, Tony R. and Dalbeth, Nicola (2021). Longitudinal development of incident gout from low-normal baseline serum urate concentrations: individual participant data analysis. BMC Rheumatology, 5 (1) 33, 33. doi: 10.1186/s41927-021-00204-4

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Sattui, Sebastian E, Conway, Richard, Putman, Michael S, Seet, Andrea M, Gianfrancesco, Milena A, Beins, Kaley, Hill, Catherine, Liew, David, Mackie, Sarah L, Mehta, Puja, Neill, Lorna, Gomez, Gimena, Salinas, Maria Isabel Haye, Maldonado, Federico Nicolas, Mariz, Henrique Ataide, de Sousa Studart, Samia Araujo, Araujo, Nafice Costa, Knight, Ann, Rozza, Davide, Quartuccio, Luca, Samson, Maxime, Bally, Stéphane, Maria, Alexandre TJ, Chazerain, Pascal, Hasseli, Rebecca, Müller-Ladner, Ulf, Hoyer, Bimba F, Voll, Reinhard, Torres, Rita Pinheiro ... Quiceno, Guillermo (2021). Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study. The Lancet Rheumatology, 3 (12), e855-e864. doi: 10.1016/S2665-9913(21)00316-7

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care

Olender, Susan A, Perez, Katherine K, Go, Alan S, Balani, Bindu, Price-Haywood, Eboni G, Shah, Nirav S, Wang, Su, Walunas, Theresa L, Swaminathan, Shobha, Slim, Jihad, Chin, BumSik, De Wit, Stéphane, Ali, Shamim M, Soriano Viladomiu, Alex, Robinson, Philip, Gottlieb, Robert L, Tsang, Tak Yin Owen, Lee, I-Heng, Hu, Hao, Haubrich, Richard H, Chokkalingam, Anand P, Lin, Lanjia, Zhong, Lijie, Bekele, B. Nebiyou, Mera-Giler, Robertino, Phulpin, Chloé, Edgar, Holly, Gallant, Joel, Diaz-Cuervo, Helena ... Bernardino, Jose I (2021). Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care. Clinical Infectious Diseases, 73 (11), E4166-E4174. doi: 10.1093/cid/ciaa1041

Characteristics, comorbidities, and outcomes of SARS-CoV-2 infection in patients with autoimmune conditions treated with systemic therapies: a population-based study

Curtis, Jeffrey R., Zhou, Xiaofeng, Rubin, David T., Reinisch, Walter, Yazdany, Jinoos, Robinson, Philip C., Chen, Yan, Benda, Birgitta, Madsen, Ann and Geier, Jamie (2021). Characteristics, comorbidities, and outcomes of SARS-CoV-2 infection in patients with autoimmune conditions treated with systemic therapies: a population-based study. Journal of Rheumatology, 49 (3), 320-329. doi: 10.3899/jrheum.210888

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

Rosas, Ivan O., Diaz, George, Gottlieb, Robert L., Lobo, Suzana M., Robinson, Philip, Hunter, Bradley D., Cavalcante, Adilson W., Overcash, J. Scott, Hanania, Nicola A., Skarbnik, Alan, Garcia-Diaz, Julia, Gordeev, Ivan, Carratalà, Jordi, Gordon, Oliver, Graham, Emily, Lewin-Koh, Nicholas, Tsai, Larry, Tuckwell, Katie, Cao, Huyen, Brainard, Diana and Olsson, Julie K. (2021). Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. Intensive Care Medicine, 47 (11), 1258-1270. doi: 10.1007/s00134-021-06507-x

Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19

Izadi, Zara, Brenner, Erica J., Mahil, Satveer K., Dand, Nick, Yiu, Zenas Z. N., Yates, Mark, Ungaro, Ryan C., Zhang, Xian, Agrawal, Manasi, Colombel, Jean-Frederic, Gianfrancesco, Milena A., Hyrich, Kimme L., Strangfeld, Anja, Carmona, Loreto, Mateus, Elsa F., Lawson-Tovey, Saskia, Klingberg, Eva, Cuomo, Giovanna, Caprioli, Marta, Cruz-Machado, Ana Rita, Mazeda Pereira, Ana Carolina, Hasseli, Rebecca, Pfeil, Alexander, Lorenz, Hanns-Martin, Hoyer, Bimba Franziska, Trupin, Laura, Rush, Stephanie, Katz, Patricia, Schmajuk, Gabriela ... Kappelman, Michael D. (2021). Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19. JAMA Network Open, 4 (10) e2129639, e2129639. doi: 10.1001/jamanetworkopen.2021.29639

Dr. Conway et al reply

Conway, Richard, Brouwer, Elisabeth, van der Geest, Kornelis S.M., Mackie, Sarah L., Mehta, Puja, Putman, Michael, Robinson, Philip and Sattui, Sebastian (2021). Dr. Conway et al reply. The Journal of Rheumatology, jrheum.210913. doi: 10.3899/jrheum.210913

Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases

Hausmann, Jonathan S, Kennedy, Kevin, Simard, Julia F, Liew, Jean W, Sparks, Jeffrey A, Moni, Tarin T, Harrison, Carly, Larché, Maggie J, Levine, Mitchell, Sattui, Sebastian E, Semalulu, Teresa, Foster, Gary, Surangiwala, Salman, Thabane, Lehana, Beesley, Richard P, Durrant, Karen L, Mateus, Elsa F, Mingolla, Serena, Nudel, Michal, Palmerlee, Candace A, Richards, Dawn P, Liew, David F L, Hill, Catherine L, Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Machado, Pedro M, Robinson, Philip C, Sufka, Paul ... Kodek, Moré A. (2021). Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. The Lancet Rheumatology, 3 (10), e707-e714. doi: 10.1016/S2665-9913(21)00175-2

Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease

Sparks, Jeffrey A., Wallace, Zachary S. and Robinson, Philip C. (2021). Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease. Current Opinion in Rheumatology, 33 (5), 412-418. doi: 10.1097/BOR.0000000000000812

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Sattui, Sebastian Eduardo, Liew, Jean W, Kennedy, Kevin, Sirotich, Emily, Putman, Michael, Moni, Tarin T, Akpabio, Akpabio, Alpízar-Rodríguez, Deshiré, Berenbaum, Francis, Bulina, Inita, Conway, Richard, Singh, Aman Dev, Duff, Eimear, Durrant, Karen L, Gheita, Tamer A, Hill, Catherine L, Howard, Richard A, Hoyer, Bimba F, Hsieh, Evelyn, El Kibbi, Lina, Kilian, Adam, Kim, Alfred Hyoungju, Liew, David F L, Lo, Chieh, Miller, Bruce, Mingolla, Serena, Nudel, Michal, Palmerlee, Candace A, Singh, Jasvinder A ... Sparks, Jeffrey A (2021). Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open, 7 (3) e001814, e001814. doi: 10.1136/rmdopen-2021-001814

Systematic review and meta-analysis of inflammatory bowel disease adverse events with anti-interleukin 17a agents and tumor necrosis factor inhibitors in rheumatic disease and skin psoriasis

Truong, Steven L., Chin, Jasmine, Liew, David F. L., Zahir, Syeda Farah, Ryan, Elizabeth G., Rubel, Diana, Radford-Smith, Graham and Robinson, Philip C. (2021). Systematic review and meta-analysis of inflammatory bowel disease adverse events with anti-interleukin 17a agents and tumor necrosis factor inhibitors in rheumatic disease and skin psoriasis. Rheumatology and Therapy, 8 (4), 1603-1616. doi: 10.1007/s40744-021-00360-6

The effect of etanercept in nonradiographic axial spondyloarthritis by stratified C‐reactive protein levels

Tam, Hoi Ki Joshua, Nash, Peter and Robinson, Philip C. (2021). The effect of etanercept in nonradiographic axial spondyloarthritis by stratified C‐reactive protein levels. ACR Open Rheumatology, 3 (10) acr2.11312, 699-706. doi: 10.1002/acr2.11312

Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al

Sparks, Jeffrey A., Wallace, Zachary S., Seet, Andrea M., Robinson, Philip C., Machado, Pedro M. and Yazdany, Jinoos (2021). Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al. Annals of the Rheumatic Diseases. doi: 10.1136/annrheumdis-2021-221157

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Sparks, Jeffrey A, Wallace, Zachary S, Seet, Andrea M, Gianfrancesco, Milena A, Izadi, Zara, Hyrich, Kimme L, Strangfeld, Anja, Gossec, Laure, Carmona, Loreto, Mateus, Elsa F, Lawson-Tovey, Saskia, Trupin, Laura, Rush, Stephanie, Katz, Patricia, Schmajuk, Gabriela, Jacobsohn, Lindsay, Wise, Leanna, Gilbert, Emily L, Duarte-Garciá, Ali, Valenzuela-Almada, Maria O, Pons-Estel, Guillermo J, Isnardi, Carolina A, Berbotto, Guillermo A, Hsu, Tiffany Y-T, D'Silva, Kristin M, Patel, Naomi J, Kearsley-Fleet, Lianne, Schäfer, Martin, Ribeiro, Sandra Lúcia Euzébio ... Yazdany, Jinoos (2021). Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Annals of the Rheumatic Diseases, 80 (9), 1137-1146. doi: 10.1136/annrheumdis-2021-220418

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Arabi, Yaseen M., Gordon, Anthony C., Derde, Lennie P. G., Nichol, Alistair D., Murthy, Srinivas, Beidh, Farah Al, Annane, Djillali, Swaidan, Lolowa Al, Beane, Abi, Beasley, Richard, Berry, Lindsay R., Bhimani, Zahra, Bonten, Marc J. M., Bradbury, Charlotte A., Brunkhorst, Frank M., Buxton, Meredith, Buzgau, Adrian, Cheng, Allen, De Jong, Menno, Detry, Michelle A., Duffy, Eamon J., Estcourt, Lise J., Fitzgerald, Mark, Fowler, Rob, Girard, Timothy D., Goligher, Ewan C., Goossens, Herman, Haniffa, Rashan, Higgins, Alisa M. ... on behalf of the REMAP-CAP Investigators (2021). Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Medicine, 47 (8), 867-886. doi: 10.1007/s00134-021-06448-5

The COVID-19 pandemic and rheumatology: impact on providing care in Latin America and around the world

Sattui, Sebastian E. and Robinson, Philip C. (2021). The COVID-19 pandemic and rheumatology: impact on providing care in Latin America and around the world. The Journal of Rheumatology, 48 (10), 1501-1503. doi: 10.3899/jrheum.210774

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Strangfeld, Anja, Schäfer, Martin, Gianfrancesco, Milena A., Lawson-Tovey, Saskia, Liew, Jean W., Ljung, Lotta, Mateus, Elsa F., Richez, Christophe, Santos, Maria J., Schmajuk, Gabriela, Scirè, Carlo A., Sirotich, Emily, Sparks, Jeffrey A., Sufka, Paul, Thomas, Thierry, Trupin, Laura, Wallace, Zachary S., Al-Adely, Sarah, Bachiller-Corral, Javier, Bhana, Suleman, Cacoub, Patrice, Carmona, Loreto, Costello, Ruth, Costello, Wendy, Gossec, Laure, Grainger, Rebecca, Hachulla, Eric, Hasseli, Rebecca, Hausmann, Jonathan S. ... COVID-19 Global Rheumatology Alliance (2021). Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases, 80 (7) e219498, 930-942. doi: 10.1136/annrheumdis-2020-219498

COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies

Whittle, Samuel L., Hazlewood, Glen S., Robinson, Philip, Johnston, Renea V., Leder, Karin, Glennon, Vanessa, Avery, Jodie C., Grobler, Liesl and Buchbinder, Rachelle (2021). COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies. Cochrane Database of Systematic Reviews, 2021 (6) CD014991, 1-16. doi: 10.1002/14651858.CD014991

COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies

Goldman, Jason D., Robinson, Philip C., Uldrick, Thomas S. and Ljungman, Per (2021). COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. Journal for ImmunoTherapy of Cancer, 9 (6) e002630. doi: 10.1136/jitc-2021-002630

Predictors of hospitalization in patients with rheumatic disease and COVID-19 in Ireland: data from the COVID-19 global rheumatology alliance registry

Conway, Richard, Nikiphorou, Elena, Demetriou, Christiana A, Low, Candice, Leamy, Kelly, Ryan, John G, Kavanagh, Ronan, Fraser, Alexander D, Carey, John J, O’Connell, Paul, Flood, Rachael M, Mullan, Ronan H, Kane, David J, Robinson, Philip C, Liew, Jean W, Grainger, Rebecca, McCarthy, Geraldine M and for the COVID-19 Global Rheumatology Alliance (2021). Predictors of hospitalization in patients with rheumatic disease and COVID-19 in Ireland: data from the COVID-19 global rheumatology alliance registry. Rheumatology Advances in Practice, 5 (2), 1-7. doi: 10.1093/rap/rkab031

Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID‐19 pandemic

Tam, Lai‐Shan, Tanaka, Yoshiya, Handa, Rohini, Li, Zhanguo, Lorenzo, Jose Paulo, Louthrenoo, Worawit, Hill, Catherine, Pile, Kevin, Robinson, Philip C., Dans, Leonila F., Hsu, Li Yang, Lee, Sang‐Min, Cho, Jiacai, Hasan, A. T. M. Tanveer, Salim, Babur, Samreen, Saba, Shaharir, Syahrul Sazliyana, Wong, Priscilla, Chau, Jeffrey, Danda, Debashish and Haq, Syed Atiqul (2021). Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID‐19 pandemic. International Journal of Rheumatic Diseases, 24 (6) 1756-185X.14124, 733-745. doi: 10.1111/1756-185x.14124

Healthcare access and attitudes towards telehealth during the early phase of the COVID ‐19 pandemic among an Australian cohort with inflammatory arthritis

Rischin, Adam, Liew, David, Black, Rachel, Fletcher, Ashley, Buchbinder, Rachelle, Lassere, Marissa, March, Lyn, Robinson, Philip C., Hill, Catherine and The ARAD Steering Committee† (2021). Healthcare access and attitudes towards telehealth during the early phase of the COVID ‐19 pandemic among an Australian cohort with inflammatory arthritis. Internal Medicine Journal, 51 (5), 788-792. doi: 10.1111/imj.15309

Patients with gout: an under-recognised group at high risk of COVID-19

Dalbeth, Nicola and Robinson, Philip C (2021). Patients with gout: an under-recognised group at high risk of COVID-19. The Lancet Rheumatology, 3 (5), e317-e318. doi: 10.1016/S2665-9913(21)00073-4

Value-based healthcare in rheumatology: axial spondyloarthritis and beyond

Liew, David F. L., Dau, Jonathan and Robinson, Philip C. (2021). Value-based healthcare in rheumatology: axial spondyloarthritis and beyond. Current Rheumatology Reports, 23 (6) 36, 36. doi: 10.1007/s11926-021-01003-z

Gout, rheumatoid arthritis, and the risk of death related to Coronavirus disease 2019: an analysis of the UK Biobank

Topless, Ruth K., Phipps‐Green, Amanda, Leask, Megan, Dalbeth, Nicola, Stamp, Lisa K., Robinson, Philip C. and Merriman, Tony R. (2021). Gout, rheumatoid arthritis, and the risk of death related to Coronavirus disease 2019: an analysis of the UK Biobank. ACR Open Rheumatology, 3 (5), 333-340. doi: 10.1002/acr2.11252

Association of race and ethnicity With COVID-19 outcomes in rheumatic disease: data from the COVID-19 Global Rheumatology Alliance Physician Registry

Gianfrancesco, Milena A, Leykina, Liza A, Izadi, Zara, Taylor, Tiffany, Sparks, Jeffrey A, Harrison, Carly, Trupin, Laura, Rush, Stephanie, Schmajuk, Gabriela, Katz, Patricia, Jacobsohn, Lindsay, Hsu, Tiffany Y, D'Silva, Kristin M, Serling-Boyd, Naomi, Wallwork, Rachel, Todd, Derrick J, Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Hausmann, Jonathan S, Liew, Jean W, Sirotich, Emily, Sufka, Paul, Wallace, Zachary S, Machado, Pedro M, Robinson, Philip C, Yazdany, Jinoos and COVID-19 Global Rheumatology Alliance (2021). Association of race and ethnicity With COVID-19 outcomes in rheumatic disease: data from the COVID-19 Global Rheumatology Alliance Physician Registry. Arthritis and Rheumatology, 73 (3), 374-380. doi: 10.1002/art.41567

Divergent effects of acute versus chronic glucocorticoids in COVID-19

Robinson, Philip C. and Morand, Eric (2021). Divergent effects of acute versus chronic glucocorticoids in COVID-19. The Lancet: Rheumatology, 3 (3), e168-e170. doi: 10.1016/S2665-9913(21)00005-9

Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance

Robinson, Philip C., Yazdany, Jinoos and Machado, Pedro M. (2021). Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance. Current Opinion in Rheumatology, 33 (2), 111-116. doi: 10.1097/BOR.0000000000000783

Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: epidemiology and outcomes

Grainger, Rebecca, Machado, Pedro M. and Robinson, Philip C. (2021). Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: epidemiology and outcomes. Best Practice and Research: Clinical Rheumatology, 35 (1) 101657, 101657. doi: 10.1016/j.berh.2020.101657

Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers

Machado, Pedro M., Schäfer, Martin, Strangfeld, Anja, Gossec, Laure, Gianfrancesco, Milena, Lawson-Tovey, Saskia, Mateus, Elsa F., Carmona, Loreto, Hyrich, Kimme L., Robinson, Philip C. and Yazdany, Jinoos (2021). Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers. Annals of the Rheumatic Diseases, annrheumdis-2021. doi: 10.1136/annrheumdis-2021-220058

A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections

McEwan, Timothy and Robinson, Philip C. (2021). A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections. Seminars in Arthritis and Rheumatism, 51 (1), 101-112. doi: 10.1016/j.semarthrit.2020.11.007

Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic disease

Robinson, Philip C. and Kim, Alfred H. J. (2021). Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic disease. Best Practice and Research Clinical Rheumatology, 35 (1) 101664, 101664. doi: 10.1016/j.berh.2021.101664

Changing COVID-19 outcomes in patients with rheumatic disease - are we really getting better at this?

Gianfrancesco, Milena A. and Robinson, Philip C. (2021). Changing COVID-19 outcomes in patients with rheumatic disease - are we really getting better at this?. The Lancet Rheumatology, 3 (2), e88-e90. doi: 10.1016/S2665-9913(21)00008-4

Correction to: Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects (Journal of Human Genetics, (2021), 66, 2, (161-169), 10.1038/s10038-020-0821-z)

Takei, Riku, Cadzow, Murray, Markie, David, Bixley, Matt, Phipps-Green, Amanda, Major, Tanya J., Li, Changgui, Choi, Hyon K., Li, Zhiqiang, Hu, Hua, Abhishek, A., Andres, M., Crisan, T., Dalbeth, N., Doherty, M., Jacobsson, L., Janssen, M., Jansen, T. L., Joosten, L. A., Kapetanovic, M., Lioté, F., Matsuo, H., McCarthy, G., Merriman, Tony R., Perez-Ruiz, F., Riches, P. L., Richette, P., Robinson, P. C., Roddy, E. ... Wei, Wen-Hua (2021). Correction to: Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects (Journal of Human Genetics, (2021), 66, 2, (161-169), 10.1038/s10038-020-0821-z). Journal of Human Genetics, 66 (2), 225-225. doi: 10.1038/s10038-020-00833-6

The prevalence of gout and hyperuricaemia in Australia: an updated systematic review

Pathmanathan, K., Robinson, Philip C., Hill, C. L. and Keen, H. I. (2021). The prevalence of gout and hyperuricaemia in Australia: an updated systematic review. Seminars in Arthritis and Rheumatism, 51 (1), 121-128. doi: 10.1016/j.semarthrit.2020.12.001

Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects

Takei, Riku, Cadzow, Murray, Markie, David, Bixley, Matt, Phipps-Green, Amanda, Major, Tanya J., Li, Changgui, Choi, Hyon K., Li, Zhiqiang, Hu, Hua, Guo, Hui, He, Meian, Shi, Yongyong, Stamp, Lisa K., Dalbeth, Nicola, Merriman, Tony R., Wei, Wen-Hua, Abhishek, A., Andres, M., Crisan, T., Dalbeth, N., Doherty, M., Jacobsson, L., Janssen, M., Jansen, T. L., Joosten, L. A., Kapetanovic, M., Lioté, F., Matsuo, H. ... Uhlig, T. (2021). Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects. Journal of Human Genetics, 66 (2), 161-169. doi: 10.1038/s10038-020-0821-z

Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective

Mackie, Sarah L., Brouwer, Elisabeth, Conway, Richard, van der Geest, Kornelis S. M., Mehta, Puja, Mollan, Susan P., Neill, Lorna, Putman, Michael, Robinson, Philip C. and Sattui, Sebastian E. (2021). Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective. The Lancet. Rheumatology, 3 (1), e71-e82. doi: 10.1016/S2665-9913(20)30386-6

Axial spondyloarthritis: concept, construct, classification and implications for therapy

Robinson, Philip C., van der Linden, Sjef, Khan, Muhammad A. and Taylor, William J. (2020). Axial spondyloarthritis: concept, construct, classification and implications for therapy. Nature Reviews Rheumatology, 17 (2), 109-118. doi: 10.1038/s41584-020-00552-4

The potential for repurposing anti-TNF as a therapy for the treatment of COVID-19

Robinson, Philip C., Liew, David F. L., Liew, Jean W., Monaco, Claudia, Richards, Duncan, Shivakumar, Senthuran, Tanner, Helen L. and Feldmann, Marc (2020). The potential for repurposing anti-TNF as a therapy for the treatment of COVID-19. Med, 1 (1), 90-102. doi: 10.1016/j.medj.2020.11.005

Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation

Amigues, Isabelle, Pearlman, Alexander H, Patel, Aarat, Reid, Pankti, Robinson, Philip C., Sinha, Rashmi, Kim, Alfred Hj, Youngstein, Taryn, Jayatilleke, Arundathi and Konig, Maximilian (2020). Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation. Expert Review of Clinical Immunology, 16 (12), 1185-1204. doi: 10.1080/1744666x.2021.1847084

Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment

Robinson, Philip C., Richards, Duncan, Tanner, Helen L. and Feldmann, Marc (2020). Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment. The Lancet Rheumatology, 2 (11), e653-e655. doi: 10.1016/S2665-9913(20)30309-X

Giant cell arteritis and COVID-19: similarities and discriminators. A systematic literature review

Mehta, Puja, Sattui, Sebastian E., van der Geest, Kornelis S. M., Brouwer, Elisabeth, Conway, Richard, Putman, Michael S., Robinson, Philip C. and Mackie, Sarah L. (2020). Giant cell arteritis and COVID-19: similarities and discriminators. A systematic literature review. The Journal of Rheumatology, 48 (7), jrheum.200766-1059. doi: 10.3899/jrheum.200766

Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: ‘Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases’ by Giollo et al

Hyrich, Kimme L, Gianfrancesco, Milena, Machado, Pedro M, Yazdany, Jinoos and Robinson, Philip C (2020). Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: ‘Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases’ by Giollo et al. Annals of the Rheumatic Diseases annrheumdis-2020-218910, annrheumdis-2020. doi: 10.1136/annrheumdis-2020-218910

Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases

Gianfrancesco, Milena, Yazdany, Jinoos and Robinson, Philip C. (2020). Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases. Current Opinion in Rheumatology, 32 (5), 434-440. doi: 10.1097/BOR.0000000000000725

The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice

Liew, Jean W., Bhana, Suleman, Costello, Wendy, Hausmann, Jonathan S., Machado, Pedro M., Robinson, Philip C., Sirotich, Emily, Sufka, Paul, Wallace, Zachary S., Yazdany, Jinoos and Grainger, Rebecca (2020). The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice. Rheumatology, 60 (1), 353-358. doi: 10.1093/rheumatology/keaa483

COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: ‘Correspondence on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials – a real-world district general hospital experience’ by Khan et al, ‘Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry’ by Gianfrancesco M et al’ by Andreica et al and ‘COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs’ by Ansarin et al

Gianfrancesco, Milena, Hyrich, Kimme L, Yazdany, Jinoos, Machado, Pedro M and Robinson, Philip C (2020). COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: ‘Correspondence on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials – a real-world district general hospital experience’ by Khan et al, ‘Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry’ by Gianfrancesco M et al’ by Andreica et al and ‘COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs’ by Ansarin et al. Annals of the Rheumatic Diseases 218713, annrheumdis-2020. doi: 10.1136/annrheumdis-2020-218713

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

Sattui, Sebastian E., Liew, Jean W., Graef, Elizabeth R., Coler-Reilly, Ariella, Berenbaum, Francis, Duarte-García, Alí, Harrison, Carly, Konig, Maximilian F., Korsten, Peter, Putman, Michael S., Robinson, Philip C., Sirotich, Emily, Ugarte-Gil, Manuel F., Webb, Kate, Young, Kristen J., Kim, Alfred H.J. and Sparks, Jeffrey A. (2020). Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Review of Clinical Immunology, 16 (7) 1744666X.2020.1792778, 1-8. doi: 10.1080/1744666X.2020.1792778

SARS CoV-2 infection among patients using immunomodulatory therapies

Winthrop, Kevin L., Brunton, Amanda E., Beekmann, Susan, Polgreen, Philip, Baddley, John, Saag, Kenneth G., Calabrese, Cassandra, Calabrese, Leonard, Robinson, Philip C., Wallace, Zachary S. and Curtis, Jeffrey R. (2020). SARS CoV-2 infection among patients using immunomodulatory therapies. Annals of the Rheumatic Diseases, 80 (2), annrheumdis-2020. doi: 10.1136/annrheumdis-2020-218580

Conducting research in a pandemic: the power of social media

Hausmann, Jonathan S., Sufka, Paul, Bhana, Suleman, Liew, Jean W., Machado, Pedro M., Wallace, Zachary S., Costello, Wendy, Robinson, Philip C., Yazdany, Jinoos, Grainger, Rebecca and Sirotich, Emily (2020). Conducting research in a pandemic: the power of social media. European Journal of Rheumatology, 7 (S2), S85-S88. doi: 10.5152/eurjrheum.2020.2066

Gout models of care: the next step is to facilitate implementation

Robinson, Philip C. (2020). Gout models of care: the next step is to facilitate implementation. International Journal of Rheumatic Diseases, 23 (9), 1115-1116. doi: 10.1111/1756-185x.13900

A pharmacokinetics‐informed approach to navigating hydroxychloroquine shortages in patients with rheumatic disease during the COVID‐19 pandemic

Scheetz, Marc H., Konig, Maximilian F., Robinson, Philip C., Sparks, Jeffrey A. and Kim, Alfred H.J. (2020). A pharmacokinetics‐informed approach to navigating hydroxychloroquine shortages in patients with rheumatic disease during the COVID‐19 pandemic. ACR Open Rheumatology, 2 (8) acr2.11164, 491-495. doi: 10.1002/acr2.11164

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Gianfrancesco, Milena, Hyrich, Kimme L., Al-Adely, Sarah, Carmona, Loreto, Danila, Maria I., Gossec, Laure, Izadi, Zara, Jacobsohn, Lindsay, Katz, Patricia, Lawson-Tovey, Saskia, Mateus, Elsa F., Rush, Stephanie, Schmajuk, Gabriela, Simard, Julia, Strangfeld, Anja, Trupin, Laura, Wysham, Katherine D., Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Hausmann, Jonathan S., Liew, Jean W., Sirotich, Emily, Sufka, Paul, Wallace, Zachary S., Yazdany, Jinoos, Machado, Pedro M. and Robinson, Philip C. (2020). Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases, 79 (7), 859-866. doi: 10.1136/annrheumdis-2020-217871

Response to: ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’ by Györfi et al

Gianfrancesco, Milena, Hyrich, Kimme L, Yazdany, Jinoos, Machado, Pedro M and Robinson, Philip C (2020). Response to: ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’ by Györfi et al. Annals of the Rheumatic Diseases, 80 (6) annrheumdis-2020-218328, annrheumdis-2020. doi: 10.1136/annrheumdis-2020-218328

Colchicine Prophylaxis of Gout Flares When Commencing Allopurinol is Very Cost Effective

Robinson, Philip C., Dalbeth, Nicola and Donovan, Peter (2020). Colchicine Prophylaxis of Gout Flares When Commencing Allopurinol is Very Cost Effective. Arthritis Care & Research, 73 (10) acr.24357, 1537-1543. doi: 10.1002/acr.24357

European consensus statements for interstitial lung disease in systemic sclerosis

Putman, Michael S., Sufka, Paul, Whittle, Samuel and Robinson, Philip C. (2020). European consensus statements for interstitial lung disease in systemic sclerosis. The Lancet Rheumatology, 2 (6), e317-e318. doi: 10.1016/S2665-9913(20)30085-0

Genomewide association study of acute anterior uveitis identifies new susceptibility loci

Huang, Xiu-Feng, Li, Zhixiu, De Guzman, Erika, Robinson, Philip, Gensler, Lianne, Ward, Michael M., Rahbar, Mohammad Hossein, Lee, MinJae, Weisman, Michael H., Macfarlane, Gary J., Jones, Gareth T., Klingberg, Eva, Forsblad-d'Elia, Helena, McCluskey, Peter, Wakefield, Denis, Coombes, Jeff S., Singh, Maria A. Fiatarone, Mavros, Yorgi, Vlahovich, Nicole, Hughes, David C., Marzo-Ortega, Helena, Van der Horste-Bruinsma, Irene, O'Shea, Finbar, Martin, Tammy M., Rosenbaum, James, Breban, Maxime, Jin, Zi-Bing, Leo, Paul, Reveille, John D. ... Brown, Matthew A. (2020). Genomewide association study of acute anterior uveitis identifies new susceptibility loci. Investigative Ophthalmology and Visual Science, 61 (6) 3, 1-12. doi: 10.1167/iovs.61.6.3

Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: ‘Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Carbillon et al

Konig, Maximilian F, Gianfrancesco, Milena, Yazdany, Jinoos and Robinson, Philip C (2020). Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: ‘Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Carbillon et al. Annals of the Rheumatic Diseases, 80 (4) e55, annrheumdis-2020. doi: 10.1136/annrheumdis-2020-217990

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

Konig, Maximilian F., Kim, Alfred H. J., Scheetz, Marc H., Graef, Elizabeth R., Liew, Jean W., Simard, Julia, Machado, Pedro M., Gianfrancesco, Milena, Yazdany, Jinoos, Langguth, Daman and Robinson, Philip C. (2020). Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Annals of the Rheumatic Diseases, 79 (10), 1-2. doi: 10.1136/annrheumdis-2020-217690

The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance

Wallace, Zachary S., Bhana, Suleman, Hausmann, Jonathan S., Robinson, Philip C., Sufka, Paul, Sirotich, Emily, Yazdany, Jinoos and Grainger, Rebecca (2020). The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. Rheumatology, 59 (6), 1204-1206. doi: 10.1093/rheumatology/keaa191

Adherence to allopurinol in patients with gout: further insights generate further questions

Robinson, Philip C. (2020). Adherence to allopurinol in patients with gout: further insights generate further questions. The Lancet Rheumatology, 2 (5), e249-e250. doi: 10.1016/S2665-9913(20)30060-6

The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic

Robinson, Philip C. and Yazdany, Jinoos (2020). The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic. Nature Reviews Rheumatology, 16 (6), 293-294. doi: 10.1038/s41584-020-0418-0

Biologic therapy for uveitis: addressing access issues is paramount

Robinson, Philip C. and Conrad, Diana (2020). Biologic therapy for uveitis: addressing access issues is paramount. Internal Medicine Journal, 50 (4), 508-509. doi: 10.1111/imj.14787

The effect of reducing systemic inflammation on serum urate

Pietsch, David E. W., Kubler, Paul and Robinson, Philip C. (2020). The effect of reducing systemic inflammation on serum urate. Rheumatology, 59 (10), 3108-3109. doi: 10.1093/rheumatology/keaa085

Author reply

Bavanendrakumar, Mathuja and Robinson, Philip C. (2020). Author reply. Internal Medicine Journal, 50 (3), 387-387. doi: 10.1111/imj.14696

Predictors of success in gout treatment

Day, Richard Osborne, Coleshill, Mathew James, Stocker, Sophie Lena, Nguyen, Amy Danh, Robinson, Philip and Aung, Eindra (2020). Predictors of success in gout treatment. The Journal of Rheumatology, 47 (3), 313-315. doi: 10.3899/jrheum.191150

Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials

Stewart, Sarah, Yang, Kevin Chih Kai, Atkins, Kate, Dalbeth, Nicola and Robinson, Philip C. (2020). Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials. Arthritis Research and Therapy, 22 (1) 28, 1-15. doi: 10.1186/s13075-020-2120-7

Axial spondyloarthritis: What is it and how is it diagnosed and managed?

Robinson, Philip C. (2020). Axial spondyloarthritis: What is it and how is it diagnosed and managed?. Medicine Today, 21 (2), 45-47.

Festina lente: Hydroxychloroquine, covid-19 and the role of the rheumatologist

Graef, Elizabeth R., Liew, Jean W., Putman, Michael S., Simard, Julia F., Sirotich, Emily, Berenbaum, Francis, Duarte-García, Alí, Grainger, Rebecca, Harrison, Carly, Konig, Maximilian F., Korsten, Peter, Proulx, Laurie, Richards, Dawn P., Robinson, Philip C., Sattui, Sebastian E., Ugarte-Gil, Manuel Francisco, Young, Kristen J., Kim, Alfred Hj, Sparks, Jeffrey A. and On behalf of COVID-19 Global Rheumatology Alliance (2020). Festina lente: Hydroxychloroquine, covid-19 and the role of the rheumatologist. Annals of the Rheumatic Diseases, 79 (6) 217480, 734-736. doi: 10.1136/annrheumdis-2020-217480

Management of autoimmune disease during the COVID-19 pandemic

Robinson, Philip C. and Bursle, Evan C. (2020). Management of autoimmune disease during the COVID-19 pandemic. Australian Prescriber, 43 (5), 146-147. doi: 10.18773/austprescr.2020.058

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

Gianfrancesco, Milena A., Hyrich, Kimme L., Gossec, Laure, Strangfeld, Anja, Carmona, Loreto, Mateus, Elsa F., Sufka, Paul, Grainger, Rebecca, Wallace, Zachary, Bhana, Suleman, Sirotich, Emily, Liew, Jean, Hausmann, Jonathan S., Costello, Wendy, Robinson, Philip, Machado, Pedro M., Yazdany, Jinoos and and theCOVID-19 Global Rheumatology Alliance Steering Committee (2020). Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. The Lancet Rheumatology, 2 (5), e250-e253. doi: 10.1016/S2665-9913(20)30095-3

Time to recognise gout as a chronic disease

Keen, Helen I., Robinson, Philip C., Dalbeth, Nicola and Hill, Catherine (2020). Time to recognise gout as a chronic disease. Medical Journal of Australia, 212 (6) mja2.50512, 285-285.e1. doi: 10.5694/mja2.50512

Gout, hyperuricaemia and crystal-associated disease network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

Bursill, David, Taylor, William J., Terkeltaub, Robert, Abhishek, Abhishek, So, Alexander K., Vargas-Santos, Ana Beatriz, Gaffo, Angelo Lino, Rosenthal, Ann, Tausche, Anne-Kathrin, Reginato, Anthony, Manger, Bernhard, Sciré, Carlo, Pineda, Carlos, Van Durme, Caroline, Lin, Ching-Tsai, Yin, Congcong, Albert, Daniel Arthur, Biernat-Kaluza, Edyta, Roddy, Edward, Pascual, Eliseo, Becce, Fabio, Perez-Ruiz, Fernando, Sivera, Francisca, Lioté, Frédéric, Schett, Georg, Nuki, George, Filippou, Georgios, McCarthy, Geraldine, Da Rocha Castelar Pinheiro, Geraldo ... Dalbeth, Nicola (2019). Gout, hyperuricaemia and crystal-associated disease network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Annals of the Rheumatic Diseases, 78 (11), 1592-1600. doi: 10.1136/annrheumdis-2019-215933

Management of patients with gout and achievement of target serum urate levels at a tertiary rheumatology service in Australia

Bavan, Mathuja and Robinson, Philip C. (2019). Management of patients with gout and achievement of target serum urate levels at a tertiary rheumatology service in Australia. Internal Medicine Journal, 50 (3) imj.14445, 337-341. doi: 10.1111/imj.14445

Non-radiographic axial spondyloarthritis (nr-axSpA): advances in classification, imaging and therapy

Robinson, Philip C., Sengupta, Raj and Siebert, Stefan (2019). Non-radiographic axial spondyloarthritis (nr-axSpA): advances in classification, imaging and therapy. Rheumatology and Therapy, 6 (2), 165-177. doi: 10.1007/s40744-019-0146-6

Gout – An update of aetiology, genetics, co-morbidities and management

Robinson, Philip C. (2018). Gout – An update of aetiology, genetics, co-morbidities and management. Maturitas, 118, 67-73. doi: 10.1016/j.maturitas.2018.10.012

Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study

Brown, Matthew A., Bird, Paul A., Robinson, Philip C., Mease, Philip J., van den Bosch, Filip, Surian, Christine, Jones, Heather, Szumski, Annette, Marshall, Lisa, Wiid, Zirke and Dougados, Maxime (2018). Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study. Annals of the Rheumatic Diseases, 77 (7), 1090-1093. doi: 10.1136/annrheumdis-2017-211313

Association of Crohn's disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin

Roberts, Rebecca L., Wallace, Mary C., Harrison, Andrew A., White, Douglas, Dalbeth, Nicola, Stamp, Lisa K., Ching, Daniel, Highton, John, Merriman, Tony R., Robinson, Philip C., Brown, Matthew A. and Stebbings, Simon M. (2018). Association of Crohn's disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin. PeerJ, 6 (6) e5088, e5088. doi: 10.7717/peerj.5088

Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout

Bursill, David, Taylor, William J., Terkeltaub, Robert, Kuwabara, Masanari, Merriman, Tony R., Grainger, Rebecca, Pineda, Carlos, Louthrenoo, Worawit, Edwards, N. Lawrence, Andrés, Mariano, Vargas-Santos, Ana Beatriz, Roddy, Edward, Pascart, Tristan, Lin, Ching-Tsai, Perez-Ruiz, Fernando, Tedeschi, Sara K., Kim, Seoyoung C., Harrold, Leslie R., McCarthy, Geraldine, Kumar, Nitin, Chapman, Peter T., Tausche, Anne-Kathrin, Vazquez-Mellado, Janitzia, Gutierrez, Marwin, Pinheiro, Geraldo da Rocha Castelar, Richette, Pascal, Pascual, Eliseo, Fisher, Mark C., Burgos-Vargas, Ruben ... Dalbeth, Nicola (2018). Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout. Arthritis Care & Research, 71 (3), 427-434. doi: 10.1002/acr.23607

Diffusion-weighted imaging is a sensitive and specific magnetic resonance sequence in the diagnosis of ankylosing spondylitis

Bradbury, Linda A., Hollis, Kelly A., Gautier, Benoît, Shankaranarayana, Sateesh, Robinson, Philip C., Saad, Nivene, Lê Cao, Kim-Anh and Brown, Matthew A (2018). Diffusion-weighted imaging is a sensitive and specific magnetic resonance sequence in the diagnosis of ankylosing spondylitis. Journal of Rheumatology, 45 (6), 771-778. doi: 10.3899/jrheum.170312

The cost-effectiveness of biannual serum urate (SU) monitoring after reaching target in gout: A health economic analysis comparing SU monitoring

Robinson, Philip C., Dalbeth, Nicola and Donovan, Peter (2018). The cost-effectiveness of biannual serum urate (SU) monitoring after reaching target in gout: A health economic analysis comparing SU monitoring. Journal of Rheumatology, 45 (5), 697-704. doi: 10.3899/jrheum.170199

EVOLVE: The Australian Rheumatology Association's 'top five' list of investigations and interventions doctors and patients should question

Morrisroe, Kathleen, Nakayama, Ayano, Soon, Jason, Arnold, Mark, Barnsley, Les, Barrett, Claire, Brooks, Peter M., Hall, Stephen, Hanrahan, Patrick, Hissaria, Pravin, Jones, Graeme, Katikireddi, Veera Srividya, Keen, Helen, Laurent, Rodger, Nikpour, Mandana, Poulsen, Katherine, Robinson, Philip, Soden, Muriel, Wood, Nigel, Cook, Nicola, Hill, Catherine and Buchbinder, Rachelle (2018). EVOLVE: The Australian Rheumatology Association's 'top five' list of investigations and interventions doctors and patients should question. Internal Medicine Journal, 48 (2), 135-143. doi: 10.1111/imj.13654

Febuxostat for the treatment of hyperuricaemia in gout

Robinson, Philip C. and Dalbeth, Nicola (2018). Febuxostat for the treatment of hyperuricaemia in gout. Expert Opinion On Pharmacotherapy, 19 (11), 1289-1299. doi: 10.1080/14656566.2018.1498842

Lesinurad for the treatment of hyperuricaemia in people with gout

Robinson, Philip C and Dalbeth, Nicola (2017). Lesinurad for the treatment of hyperuricaemia in people with gout. Expert opinion on pharmacotherapy, 18 (17), 1875-1881. doi: 10.1080/14656566.2017.1401609

Epidemiology of inpatient gout in Australia and New Zealand: temporal trends, comorbidities and gout flare site

Robinson, Philip C., Kempe, Sarina, Tebbutt, Ian and Roberts, Lynden (2017). Epidemiology of inpatient gout in Australia and New Zealand: temporal trends, comorbidities and gout flare site. International Journal of Rheumatic Diseases, 20 (6), 779-784. doi: 10.1111/1756-185X.12941

Genetic diagnostic profiling in axial spondyloarthritis: a real-world study

Thomas, G., Willner, D., Robinson, P., Cortes, A., Duan, R., Rudwaleit, M., Akkoc, N., Braun, J., Chou, C., Maksymowych, W., Ozgocmen, S., Roussou, E., Sieper, J., Valle-Onate, R., van der Heijde, D., Wei, J., Leo, P. and Brown, M. (2017). Genetic diagnostic profiling in axial spondyloarthritis: a real-world study. Clinical and Experimental Rheumatology, 35 (2), 229-233.

Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand

Truong, Steven L., Saad, Nivene F., Robinson, Philip C., Cowderoy, Greg, Lim, Irwin, Schachna, Lionel, Stebbings, Simon, Stuckey, Stephen, Taylor, Andrew L., Whittle, Samuel L., Zochling, Jane, Bird, Paul and Brown, Matthew A. (2017). Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand. Journal of Medical Imaging and Radiation Oncology, 61 (1), 58-69. doi: 10.1111/1754-9485.12573

Management of gout - reply

Robinson, Philip C. and Stamp, Lisa K. (2016). Management of gout - reply. Australian Family Physician, 45 (9), 618-619.

Management of thyroid disease in pregnancy – room for improvement in the first trimester

Robinson, Helen, Robinson, Philip, D'Emden, Michael and Mahomed, Kassam (2016). Management of thyroid disease in pregnancy – room for improvement in the first trimester. Obstetric Medicine, 9 (3), 126-129. doi: 10.1177/1753495X16629773

Insight into rheumatological cause and effect through the use of Mendelian randomization

Robinson, Philip C., Choi, Hyon K., Do, Ron and Merriman, Tony R. (2016). Insight into rheumatological cause and effect through the use of Mendelian randomization. Nature Reviews Rheumatology, 12 (8), 486-493. doi: 10.1038/nrrheum.2016.102

Exome-wide study of ankylosing spondylitis demonstrates additional shared genetic background with inflammatory bowel disease

Robinson, Philip C., Leo, Paul J, Pointon, Jennifer J., Harris, Jessica, Cremin, Katie, Bradbury, Linda A., Stebbings, Simon, Harrison, Andrew A., Australian Osteoporosis Genetics Consortium, Wellcome Trust Case Control Consortium, Management Committee, Data and Analysis Group, DNA, Genotyping, Data QC and Informatics Group, Publications Committee, Duncan, Emma L., Evans, David M., Wordsworth, Paul B. and Brown, Matthew A. (2016). Exome-wide study of ankylosing spondylitis demonstrates additional shared genetic background with inflammatory bowel disease. NPJ Genomic Medicine, 1 (1) 16008, 16008-6. doi: 10.1038/npjgenmed.2016.8

The management of gout: much has changed

Robinson, Philip C. and Stamp, Lisa K. (2016). The management of gout: much has changed. Australian Family Physician, 45 (5), 299-302.

The genetic associations of acute anterior uveitis and their overlap with the genetics of ankylosing spondylitis

Robinson, P. C., Leo, P. J., Pointon, J. J., Harris, J., Cremin, K., Bradbury, L. A., Wellcome Trust Case Control Consortium, Australasian Osteoporosis Genetics Consortium (AOGC), Stebbings, S., Harrison, A. A., Evans, D. M., Duncan, E. L., Wordsworth, B. P. and Brown, M. A. (2016). The genetic associations of acute anterior uveitis and their overlap with the genetics of ankylosing spondylitis. Genes and Immunity, 17 (1), 46-51. doi: 10.1038/gene.2015.49

The ASAS criteria for axial spondyloarthritis: strengths, weaknesses, and proposals for a way forward

van der Linden, Sjef, Akkoc, Nurullah, Brown, Matthew A., Robinson, Philip C. and Khan, Muhammad A. (2015). The ASAS criteria for axial spondyloarthritis: strengths, weaknesses, and proposals for a way forward. Current Rheumatology Reports, 17 (9) 62, 62.1-62.12. doi: 10.1007/s11926-015-0535-y

An observational study of gout prevalence and quality of care in a national Australian general practice population

Robinson, Philip C., Taylor, William J. and Dalbeth, Nicola (2015). An observational study of gout prevalence and quality of care in a national Australian general practice population. Journal of Rheumatology, 42 (9), 1702-1707. doi: 10.3899/jrheum.150310

Evaluating the performance of fine-mapping strategies at common variant GWAS Loci

van de Bunt, Martijn, Cortes, Adrian, Brown, Matthew A., Morris, Andrew P., McCarthy, Mark I., IGAS Consortium, Hadler, Johanna, Robinson, Philip C., Leo, Paul, Cremin, Katie, Pryce, Karena, Harris, Jessica, Bradbury, Linda A., Kenna, Tony J. and Yang, Jian (2015). Evaluating the performance of fine-mapping strategies at common variant GWAS Loci. PL o S Genetics, 11 (9) e1005535, 1-14. doi: 10.1371/journal.pgen.1005535

ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients

Robinson, Philip C., Costello, Mary-Ellen, Leo, Paul, Bradbury, Linda A., Hollis, Kelly, Cortes, Adrian, Lee, Seunghun, Joo, Kyung Bin, Shim, Seung-Cheol, Weisman, Michael, Ward, Michael, Zhou, Xiaodong, Garchon, Henri-Jean, Chiocchia, Gilles, Nossent, Johannes, Lie, Benedicte A., Forre, Oystein, Tuomilehto, Jaakko, Laiho, Kari, Jiang, Lei, Liu, Yu, Wu, Xin, Elewaut, Dirk, Burgos-Vargas, Ruben, Gensler, Lianne S., Stebbings, Simon, Haroon, Nigil, Mulero, Juan, Luis Fernandez-Sueiro, Jose ... Brown, Matthew A. (2015). ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients. Annals of the Rheumatic Diseases, 74 (8), 1627-1629. doi: 10.1136/annrheumdis-2015-207416

Correspondence: Does midlife obesity really lower dementia risk?

Robinson, Philip C. and Merriman, Tony R. (2015). Correspondence: Does midlife obesity really lower dementia risk?. Lancet Diabetes & Endocrinology, 3 (7), 501-501. doi: 10.1016/s2213-8587(15)00218-1

ERAP2 functional knockout in humans does not alter surface heavy chains or HLA-B27, inflammatory cytokines or endoplasmic reticulum stress markers

Robinson, Philip C., Lau, Eugene, Keith, Patricia, Lau, Max C., Thomas, Gethin P., Bradbury, Linda A., Brown, Matthew A. and Kenna, Tony J. (2015). ERAP2 functional knockout in humans does not alter surface heavy chains or HLA-B27, inflammatory cytokines or endoplasmic reticulum stress markers. Annals of the Rheumatic Diseases, 74 (11), 2092-2095. doi: 10.1136/annrheumdis-2015-207467

Endoplasmic reticulum aminopeptidases in the pathogenesis of ankylosing spondylitis

Kenna, Tony J., Robinson, Philip C. and Haroon, Nigil (2015). Endoplasmic reticulum aminopeptidases in the pathogenesis of ankylosing spondylitis. Rheumatology (United Kingdom), 54 (9), 1549-1556. doi: 10.1093/rheumatology/kev218

Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1

Cortes, Adrian, Pulit, Sara L., Leo, Paul J., Pointon, Jenny J., Robinson, Philip C., Weisman, Michael H., Ward, Michael, Gensler, Lianne S., Zhou, Xiaodong, Garchon, Henri-J., Chiocchia, Gilles, Nossent, Johannes, Lie, Benedicte A., Forre, Oystein, Tuomilehto, Jaakko, Laiho, Kari, Bradbury, Linda A., Elewaut, Dirk, Burgos-Vargas, Ruben, Stebbings, Simon, Appleton, Louise, Farrah, Claire, Lau, Jonathan, Haroon, Nigil, Mulero, Juan, Blanco, Francisco J., Gonzalez-Gay, Miguel A., Lopez-Larrea, C., Bowness, Paul ... Brown, Matthew A. (2015). Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nature Communications, 6 (7146) 7146, 1-8. doi: 10.1038/ncomms8146

ERAP1 biology and assessment in Ankylosing Spondylitis

Robinson, Philip C. and Brown, Matthew A. (2015). ERAP1 biology and assessment in Ankylosing Spondylitis. Proceedings of the National Academy of Sciences of the United States of America, 112 (15), E1816-E1816. doi: 10.1073/pnas.1501475112

Advances in pharmacotherapy for the treatment of gout

Robinson, Philip C. and Dalbeth, Nicola (2015). Advances in pharmacotherapy for the treatment of gout. Expert Opinion On Pharmacotherapy, 16 (4), 533-546. doi: 10.1517/14656566.2015.997213

Brief report: intestinal dysbiosis in ankylosing spondylitis

Costello, Mary-Ellen, Ciccia, Francesco, Willner, Dana, Warrington, Nicole, Robinson, Philip C., Gardiner, Brooke, Marshall, Mhairi, Kenna, Tony J., Triolo. Giovanni and Brown, Matthew A. (2015). Brief report: intestinal dysbiosis in ankylosing spondylitis. Arthritis and Rheumatology, 67 (3), 686-691. doi: 10.1002/art.38967

Advances in classification, basic mechanisms and clinical science in ankylosing spondylitis and axial spondyloarthritis

Robinson, P. C. and Benham, H. (2015). Advances in classification, basic mechanisms and clinical science in ankylosing spondylitis and axial spondyloarthritis. Internal Medicine Journal, 45 (2), 127-133. doi: 10.1111/imj.12544

Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis

Robinson, Philip C., Claushuis, Theodora A. M., Cortes, Adrian, Martin, Tammy M., Evans, David M., Leo, Paul, Mukhopadhyay, Pamela, Bradbury, Linda A., Cremin, Katie, Harris, Jessica, Maksymowych, Walter P., Inman, Robert D., Rahman, Proton, Haroon, Nigil, Gensler, Lianne, Powell, Joseph E., Van Der Horst-Bruinsma, Irene E., Hewitt, Alex W., Craig, Jamie E., Lim, Lyndell L., Wakefield, Denis, McCluskey, Peter, Voigt, Valentina, Fleming, Peter, Spondyloarthritis Research Consortium of Canada, Australio-Anglo-American Spondylitis Consortium, International Genetics of Ankylosing Spondylitis Consortium, Wellcome Trust Case Control Study 2, Degli-Esposti, Mariapia ... Brown, Matthew A. (2015). Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis. Arthritis and Rheumatology, 67 (1), 140-151. doi: 10.1002/art.38873

Role of genetics in infection-associated arthritis

Benham, Helen, Robinson, Philip C., Baillet, Athan C., Rehaume, Linda M. and Thomas, Ranjeny (2015). Role of genetics in infection-associated arthritis. Best Practice and Research: Clinical Rheumatology, 29 (2), 213-225. doi: 10.1016/j.berh.2015.02.002

The intestinal microbiome in human disease and how it relates to arthritis and spondyloarthritis

Costello, Mary-Ellen, Robinson, Philip C., Benham, Helen and Brown, Matthew A. (2015). The intestinal microbiome in human disease and how it relates to arthritis and spondyloarthritis. Best Practice and Research: Clinical Rheumatology, 29 (2), 202-212. doi: 10.1016/j.berh.2015.08.001

Poor compliance with community-acquired pneumonia antibiotic guidelines in a large Australian private hospital emergency department

Robinson, Helen L., Robinson, Philip C. and Whitby, Michael (2014). Poor compliance with community-acquired pneumonia antibiotic guidelines in a large Australian private hospital emergency department. Microbial Drug Resistance, 20 (6), 561-567. doi: 10.1089/mdr.2014.0064

Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis

Kenna, T. J., Lau, M. C., Keith, P., Ciccia, F., Costello, M. -E., Bradbury, L., Low, P. -L., Agrawal, N., Triolo, G., Alessandro, R., Robinson, P. C., Thomas, G. P. and Brown, M. A. (2014). Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis. Genes and Immunity, 16 (1), 35-42. doi: 10.1038/gene.2014.62

Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA)

Robinson, Philip C., Bird, Paul, Lim, Irwin, Saad, Nivene, Schachna, Lionel, Taylor, Andrew L., Whittle, Samuel L. and Brown, Matthew A. (2014). Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA). International Journal of Rheumatic Diseases, 17 (5), 548-556. doi: 10.1111/1756-185X.12358

The window of opportunity: A relevant concept for axial spondyloarthritis

Robinson, Philip C. and Brown, Matthew A. (2014). The window of opportunity: A relevant concept for axial spondyloarthritis. Arthritis Research and Therapy, 16 (3) 109. doi: 10.1186/ar4561

Genetics of ankylosing spondylitis

Robinson, Philip C. and Brown, Matthew A. (2014). Genetics of ankylosing spondylitis. Molecular Immunology, 57 (1), 2-11. doi: 10.1016/j.molimm.2013.06.013

Gout: Joints and beyond, epidemiology, clinical features, treatment and co-morbidities

Robinson, Philip C. and Horsburgh, Simon (2014). Gout: Joints and beyond, epidemiology, clinical features, treatment and co-morbidities. Maturitas, 78 (4), 245-251. doi: 10.1016/j.maturitas.2014.05.001

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

Cortes, Adrian, Hadler, Johanna, Pointon, Jenny P., Robinson, Philip C., Karaderi, Tugce, Leo, Paul, Cremin, Katie, Pryce, Karena, Harris, Jessica, Lee, Seunghun, Joo, Kyung Bin, Shim, Seung-Cheol, Weisman, Michael, Ward, Michael, Zhou, Xiaodong, Garchon, Henri-Jean, Chiocchia, Gilles, Nossent, Johannes, Lie, Benedicte A., Førre, Øystein, Tuomilehto, Jaakko, Laiho, Kari, Jiang, Lei, Liu, Yu, Wu, Xin, Bradbury, Linda A., Elewaut, Dirk, Burgos-Vargas, Ruben, Stebbings, Simon ... Wellcome Trust Case Control Consortium 2 (WTCCC2) (2013). Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nature Genetics, 45 (7), 730-740. doi: 10.1038/ng.2667

A qualitative and quantitative analysis of the characteristics of gout patient education resources

Robinson, Philip C. and Schumacher, H. Ralph, Jr. (2013). A qualitative and quantitative analysis of the characteristics of gout patient education resources. Clinical Rheumatology, 32 (6), 771-778. doi: 10.1007/s10067-013-2168-8

Author reply

Robinson, P. C., Taylor, W. J. and Merriman, T. R. (2013). Author reply. Internal Medicine Journal, 43 (4), 466-466. doi: 10.1111/imj.12094

Classification criteria: peripheral spondyloarthropathy and psoriatic arthritis

Taylor, William J. and Robinson, Philip C. (2013). Classification criteria: peripheral spondyloarthropathy and psoriatic arthritis. Current Rheumatology Reports, 15 (4) 317. doi: 10.1007/s11926-013-0317-3

Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondylitis

Robinson, Philip Cameron, Wordsworth, Bryan Paul, Reveille, John D. and Brown, Matthew A. (2013). Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondylitis. Annals of the Rheumatic Diseases, 72 (2), 162-164. doi: 10.1136/annrheumdis-2012-202073

Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999–2009

Robinson, Philip C., Merriman, Tony R., Herbison, Peter and Highton, John (2012). Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999–2009. Rheumatology, 52 (1) kes253, 118-126. doi: 10.1093/rheumatology/kes253

Systematic review of the prevalence of gout and hyperuricaemia in Australia

Robinson, P. C., Taylor, W. J. and Merriman, T. R. (2012). Systematic review of the prevalence of gout and hyperuricaemia in Australia. Internal Medicine Journal, 42 (9), 997-1007. doi: 10.1111/j.1445-5994.2012.02794.x

The genetics of ankylosing spondylitis and axial spondyloarthritis

Robinson, Philip C. and Brown, Matthew A. (2012). The genetics of ankylosing spondylitis and axial spondyloarthritis. Rheumatic Disease Clinics of North America, 38 (3), 539-553. doi: 10.1016/j.rdc.2012.08.018

Time to Treatment in Rheumatoid Arthritis : Factors Associated With Time to Treatment Initiation and Urgent Triage Assessment of General Practitioner Referrals

Robinson, Philip C. and Taylor, William J. (2010). Time to Treatment in Rheumatoid Arthritis : Factors Associated With Time to Treatment Initiation and Urgent Triage Assessment of General Practitioner Referrals. JCR: Journal of Clinical Rheumatology, 16 (6), 267-273. doi: 10.1097/rhu.0b013e3181eeb499

Baseline Mri/crp as Predictors of Response to Etanercept in the Management of Patients with Non-Radiographic Axial Spondyloarthritis

Brown, M., Bird, P., Robinson, P., Mease, P., Van Den Bosch, F., Surian, C., Wiid, Z., Johnson, H., Szumski, A. and Marshall, L. (2015). Baseline Mri/crp as Predictors of Response to Etanercept in the Management of Patients with Non-Radiographic Axial Spondyloarthritis. Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association, Adelaide, SA, Australia, 23-26 May 2015. Richmond, VIC, Australia: Wiley-Blackwell.

Co-morbidities and mortality in admitted scleroderma patients using a hospital-based population in New Zealand, 1999-2012

Horsburgh, S., Highton, J., Stevanovic, V and Robinson, P. (2015). Co-morbidities and mortality in admitted scleroderma patients using a hospital-based population in New Zealand, 1999-2012. Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association, 56th Annual Scientific Meeting, Adelaide, Australia, 23–26 May 2015. HOBOKEN: WILEY-BLACKWELL. doi: 10.1111/imj.12752

Diffusion Weighted Imaging Is a Sensitive and Specific MRI Protocol for the Diagnosis and Assessment of Disease Severity in Ankylosing Spondylitis

Bradbury, Linda A., Hollis, Kelly A., Gautier, Benoit, Shankaranarayana, Sateesh, Robinson, Philip, Saad, Nivene, Le Cao, Kim-Anh and Brown, Matthew A. (2015). Diffusion Weighted Imaging Is a Sensitive and Specific MRI Protocol for the Diagnosis and Assessment of Disease Severity in Ankylosing Spondylitis. unknown, unknown, unknown. HOBOKEN: WILEY-BLACKWELL.

Exomewide association study of ankylosing spondylitis identifies additional coding region genetic associations with as and strengthens evidence of shared genetic background with inflammatory bowel disease

Robinson, P., Leo, P., Pointon, J., Harris, J., Cremin, K., Bradbury, L., Stebbings, S., Harrison, A., Duncan, E., Wordsworth, P. and Brown, M. (2015). Exomewide association study of ankylosing spondylitis identifies additional coding region genetic associations with as and strengthens evidence of shared genetic background with inflammatory bowel disease. Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association, 56th Annual Scientific Meeting, Adelaide, South Australia, Australia, 23–26 May 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/imj.12752

Gout prevalence and quality of care in an Australian general practice population

Robinson, P., Taylor, W. and Dalbeth, N. (2015). Gout prevalence and quality of care in an Australian general practice population. Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association, 56th Annual Scientific Meeting, Adelaide, South Australia, 23–26 May 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/imj.12752

ERAP2 Functional Knockout In Humans Does Not Alter ER Stress Or Evidence Of HLA-B27 Misfolding In Ankylosing Spondylitis.

Robinson, Philip, Wang, Yang, Lau, Eugene, Keith, Patricia, Kenna, Tony and Brown, Matthew A. (2013). ERAP2 Functional Knockout In Humans Does Not Alter ER Stress Or Evidence Of HLA-B27 Misfolding In Ankylosing Spondylitis.. 77th Annual Meeting of the American College of Rheumatology / 48th Annual Meeting of the Association of Rheumatology Health Professionals, San Diego Ca, 25-30 October 2013. Hoboken, NJ United States: John Wiley and Sons Inc.. doi: 10.1002/art.38216

Genetic Associations In Anterior Uveitis Implicate T-Cell Co-Stimulation and Other Immune Pathways

Robinson, Philip, Claushuis, Dorith, Leo, Paul, Mukhopadhyay, Pamela, Wordsworth, P., Weisman, Michael H., Maksymowych, Walter P., Rahman, Proton, Inman, Robert, Hewitt, Alex, Martin, Tammy M., Rosenbaum, James T., Wakefield, Dennis, Reveille, John D. and Brown, Matthew A. (2013). Genetic Associations In Anterior Uveitis Implicate T-Cell Co-Stimulation and Other Immune Pathways. 77th Annual Meeting of the American College of Rheumatology / 48th Annual Meeting of the Association of Rheumatology Health Professionals, San Diego CA, United States, 25-30 October 2013 Proceedings title Abstract Supplement 2013 Annual Meeting. Hoboken, NJ United States: John Wiley and Sons. doi: 10.1002/art.38216

Ustekinumab in Ankylosing Spondylitis and Ulcerative Colitis

Bradbury, L., Hollis, K., Chay, J., Robinson, P. and Brown, M. (2013). Ustekinumab in Ankylosing Spondylitis and Ulcerative Colitis. 54th Annual Scientific Meeting of the Australian Rheumatology Association in conjunction with the Rheumatology Health Professionals Association, Perth, WA Australia, 18 -22 May 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/imj.12142

Ankylosing spondylitis is associated with single nucleotide polymorphisms in loci implicating four aminopeptidases

Robinson, Philip, Cortes, Adrian, Leo, Paul, Evans, David and Brown, Matthew A. (2012). Ankylosing spondylitis is associated with single nucleotide polymorphisms in loci implicating four aminopeptidases. Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, DC, United States, 9-14 November 2012. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/art.37735

Ankylosing spondylitis is associated with snps in loci implicating four aminopeptidases

Robinson, P. C., Cortes, A., Leo, P., Evans, D. M. and Brown, M. A. (2012). Ankylosing spondylitis is associated with snps in loci implicating four aminopeptidases. 8th International Congress on Spondyloarthritis, Granada, Spain, 9-13 May 2012. Ospedaletto, Italy: Pacini Editore SpA.

Dense genotyping of candidate genes identifies 16 new susceptibility loci in ankylosing spondylitis

Cortes, Adrian, Robinson, Philip and Brown, Matthew A. (2012). Dense genotyping of candidate genes identifies 16 new susceptibility loci in ankylosing spondylitis. Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, DC, United States, 9-14 November 2012. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/art.37735

Dense genotyping of candidate genes identifies 16 new susceptibility loci in ankylosing spondylitis

Cortes, A., Robinson, P. C., Hadler, J., Leo, P., Evans, D. M. and Brown, M. A. (2012). Dense genotyping of candidate genes identifies 16 new susceptibility loci in ankylosing spondylitis. Eighth International Congress on Spondyloarthropathies, Gent, Belgium, 4-6 October 2012. Ospedaletto, PI, Italy: Pacini Editore.

Diffusion-weighted magnetic resonance imaging in the detection of sacroiliitis

Saad, N., Bradbury, L., McFarlane, J., Hollis, K., Brown, M. and Robinson, P. (2012). Diffusion-weighted magnetic resonance imaging in the detection of sacroiliitis. Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting Conference, Canberra, ACT Australia, 12-15 May 2012. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Disease-associated erapi variants do not alter endoplasmic reticulum stress in ankylosing spondylitis

Kenna, T. J., Lau, M. C., Costello, M. E., Robinson, P. and Brown, M. A. (2012). Disease-associated erapi variants do not alter endoplasmic reticulum stress in ankylosing spondylitis. 8th International Congress on Spondyloarthritis, Granada, Spain, 9-13 May 2012. Ospedaletto, Italy: Pacini Editore SpA.

Recent advances in biological therapies in rheumatic diseases

Robinson, Philip (2012). Recent advances in biological therapies in rheumatic diseases. RACP Future Directions in Health Congress 2012, Brisbane, Australia, 6-9 May 2012. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1445-5994.2012.02779.x

Tnfi failures: experience in a specialist ankylosing spondylitis clinic

Bradbury, L., McFarlane, J., Robinson, P. and Brown, M. (2012). Tnfi failures: experience in a specialist ankylosing spondylitis clinic. Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting Conference, Canberra, ACT Australia, 12-15 May 2012. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

The genetics of ankylosing spondylitis and anterior uveitis

Robinson, Philip C. (2014). The genetics of ankylosing spondylitis and anterior uveitis. PhD Thesis, UQ Diamantina Institute, The University of Queensland. doi: 10.14264/uql.2015.24